MedRx Co., Ltd (TYO:4586)

MedRx Statistics

Total Valuation

MedRx has a market cap or net worth of JPY 7.10 billion. The enterprise value is 5.44 billion.

Market Cap	7.10B
Enterprise Value	5.44B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MedRx has 55.50 million shares outstanding. The number of shares has increased by 23.37% in one year.

Current Share Class	55.50M
Shares Outstanding	55.50M
Shares Change (YoY)	+23.37%
Shares Change (QoQ)	+6.82%
Owned by Insiders (%)	3.37%
Owned by Institutions (%)	-6.55%
Float	49.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	161.44
PB Ratio	3.79
P/TBV Ratio	3.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.96
EV / Sales	123.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.24

Current Ratio	28.24
Quick Ratio	27.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.03% and return on invested capital (ROIC) is -36.32%.

Return on Equity (ROE)	-63.03%
Return on Assets (ROA)	-35.46%
Return on Invested Capital (ROIC)	-36.32%
Return on Capital Employed (ROCE)	-67.68%
Revenue Per Employee	2.00M
Profits Per Employee	-62.45M
Employee Count	22
Asset Turnover	0.02
Inventory Turnover	0.07

Taxes

In the past 12 months, MedRx has paid 12.00 million in taxes.

Income Tax	12.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.13% in the last 52 weeks. The beta is 0.71, so MedRx's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+39.13%
50-Day Moving Average	126.76
200-Day Moving Average	87.57
Relative Strength Index (RSI)	46.55
Average Volume (20 Days)	4,070,305

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedRx had revenue of JPY 44.00 million and -1.37 billion in losses. Loss per share was -28.69.

Revenue	44.00M
Gross Profit	43.00M
Operating Income	-1.27B
Pretax Income	-1.36B
Net Income	-1.37B
EBITDA	-1.24B
EBIT	-1.27B
Loss Per Share	-28.69

Balance Sheet

The company has 1.67 billion in cash and n/a in debt, giving a net cash position of 1.67 billion or 30.04 per share.

Cash & Cash Equivalents	1.67B
Total Debt	n/a
Net Cash	1.67B
Net Cash Per Share	30.04
Equity (Book Value)	1.87B
Book Value Per Share	34.99
Working Capital	1.69B

Cash Flow

Operating Cash Flow	-1.24B
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	97.73%
Operating Margin	-2,879.55%
Pretax Margin	-3,095.45%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.37%
Shareholder Yield	-23.37%
Earnings Yield	-19.34%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedRx has an Altman Z-Score of 37.82 and a Piotroski F-Score of 1.

Altman Z-Score	37.82
Piotroski F-Score	1